MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection

Phosphopeptide analyses of the simian virus 10 (SV40) large tumor antigen (LT) in S410-transformed rat cells, as well as in SV40 lytically infected monkey cells, showed that gel-purified LT that was not complexed to p53 (free LT) and p53-complexed LT differed substantially in their phosphorylation patterns, Most significantly, p53-complexed LT contained phosphopeptides not found in free LT, We show that these additional phosphopeptides were derived from MDM2, a cellular antagonist of p53, which coprecipitated with the p53-LT complexes, probably in a trimeric LT-p53-MDM2 complex, MDM2 also quantitatively bound the free p53 in SV40-transformed cells, Free LT, in contrast, was not found in complex with MDM2, indicating a specific targeting of the MDM2 protein by SV40. This specificity is underscored by significantly different phosphorylation patterns of the MDM2 proteins in normal and SV40-transformed cells, Furthermore, the MDM2 protein, like p53, becomes metabolically stabilized its SV 10-transformed cells, This suggests the possibility that the specific targeting of MDM2 by SV40 is aimed at preventing MDM2-directed proteasomal degradation of p53 in SV40-infected and -transformed cells, thereby leading to metabolic stabilization of p53 in these cells.